- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A summary of the cases who used an adrenaline auto-injector prescribed in our department
-
- Nakata Joon
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Sasaki Kemal
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Matsui Teruaki
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Nakagawa Tomoko
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Sugiura Shiro
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Kando Naoyuki
- Department of Allergy, Aichi Children's Health and Medical Center
-
- Ito Komei
- Department of Allergy, Aichi Children's Health and Medical Center
Bibliographic Information
- Other Title
-
- 当科で処方したアドレナリン自己注射薬（エピペン<sup>®</sup>）の使用事例報告
Search this article
Description
Background: The number of patients who use an adrenaline auto-injector (AAI, Epipen®) is relatively small in Japan, with a usage rate of approximately 1% of the prescribed AAIs. Obtaining practical information on patients who have used these devices would be helpful to predict various scenarios that might occur during any emergency. Method: We retrospectively evaluated the detailed medical records of the patients who used an AAI. Results: There were 25 cases who used an AAI from August 2005 to December 2013. The situations of the causative intake were eating at a restaurant or purchased products (n=10), school lunch (n=8) and oral immunotherapy (n=7). At the time of discovery, about 70% of the cases were presenting with Grade 1-2 on the anaphylaxis grading classification, and only 28% of the cases were discovered with Grade 4 symptoms. The median time between discovery and AAI usage was 20 minutes (0-300 minutes), and was generally less than one hour. Discussion: The cases with absolute indications for AAI use at the onset were limited, and, in many cases, the symptoms progressed to the indication level after discovery. At the time of prescription, it is important for physicians to instruct patients on a systematic approach to treatment, including frequent evaluation of the symptoms, in order to ensure the appropriate timing of injection.
Journal
-
- Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology
-
Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology 28 (5), 796-805, 2014
THE JAPANESE SOCIETY OF PEDIATRIC ALLERGY AND CLINICAL IMMUNOLOGY
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679453336832
-
- NII Article ID
- 130004852348
-
- ISSN
- 18822738
- 09142649
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed